Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Short LLY ETF

8.57
0.0000
Volume:- -
Turnover:- -
Market Cap:1.54M
PE:- -
High:8.57
Open:8.57
Low:8.57
Close:8.57
52wk High:21.15
52wk Low:7.63
Shares:180.00K
Float Shares:180.00K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound's cash sales

Dow Jones
·
Mar 18

BUZZ-Eli Lilly slips after HSBC downgrade

Reuters
·
Mar 18

Eli Lilly Cut to Reduce From Hold by HSBC

Dow Jones
·
Mar 18

Eli Lilly Shares Extend Losses, Last Down 5%

THOMSON REUTERS
·
Mar 18

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
Mar 18

Eli Lilly Shares Decline Over 4% as Structure Therapeutics Reports Positive Data for Experimental Weight-Loss Drug

Stock News
·
Mar 17

Eli Lilly Stock Gets Downgraded. It Faces Stiff Headwinds After Strong Run-Up. -- Barrons.com

Dow Jones
·
Mar 17

US STOCKS-Wall St set to open higher as investors weigh energy costs before Fed call

Reuters
·
Mar 17

Wells Fargo Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

TIPRANKS
·
Mar 17

Eli Lilly Shares Down 1.5% Premarket After HSBC Cuts to Reduce From Hold

THOMSON REUTERS
·
Mar 17

Eli Lilly downgraded to Reduce from Hold at HSBC

TIPRANKS
·
Mar 17

U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson

Reuters
·
Mar 17

Eli Lilly & Co : HSBC Cuts to Reduce From Hold

THOMSON REUTERS
·
Mar 17

Celltrion signs KRW 294.9 billion CMO drug substance supply deal for 2027-2029

Reuters
·
Mar 17

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 17

RBC Capital Markets Pounds the Table on Eli Lilly Stock (LLY) as Share Price Falls

TIPRANKS
·
Mar 17

Lilly's EBGLYSS (Lebrikizumab-Lbkz) Is The First And Only Selective Il-13 Inhibitor To Deliver Positive Phase 3 Outcomes In Patients Aged Six Months To 18 Years With Moderate-To-Severe Atopic De

Reuters
·
Mar 16

Eli Lilly - New Zepbound (Tirzepatide) Kwikpen Starting at $299 per Month for 2.5 Mg Dose

THOMSON REUTERS
·
Mar 16

Eli Lilly - Zepbound (Tirzepatide) Kwikpen NOW Available at Self-Pay Pricing at Major Pharmacies Nationwide in Addition to Lillydirect

THOMSON REUTERS
·
Mar 16

Eli Lilly reports Phase 3 ADorable-1 trial shows EBGLYSS achieves 63% EASI-75 and 44% IGA 0/1 at week 16 in pediatric atopic dermatitis

Reuters
·
Mar 16